Tag: Nasdaq:ANNX

Annexon Bolsters Ophthalmology Expertise with Appointment of Retina Specialist Lloyd Clark, M.D., as Pivotal ANX007 Program Advances in Dry Age-Related Macular Degeneration (AMD) with...

Dr. Clark Brings 25 Years of Experience Treating Retina Diseases and Developing Emerging Therapies as a Principal Investigator in Over 70 Clinical Trials and as an Early Pioneer of VEGF Inhibitors

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsNasdaq:ANNX

March of Dimes Statement on the Passage of H.R. 1

Neuro Balance Therapy Update: Strongest Non-Clinical Reflex Routine for Seniors Concerned About Instability

LGI Homes, Inc. Reports June and Second Quarter 2025 Home Closings and Announces Date for Second Quarter Earnings Conference Call

Tag: Nasdaq:ANNX

Annexon Bolsters Ophthalmology Expertise with Appointment of Retina Specialist Lloyd Clark, M.D., as Pivotal ANX007 Program Advances in Dry Age-Related Macular Degeneration (AMD) with...

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us